W M Admiraal1, F Holleman2, M B Snijder3, R J G Peters4, L M Brewster5, J B L Hoekstra2, K Stronks3, I G M van Valkengoed3. 1. Department of Public Health, Academic Medical Center, Amsterdam, The Netherlands; Department of Internal Medicine, Academic Medical Center, Amsterdam, The Netherlands. Electronic address: w.m.admiraal@amc.uva.nl. 2. Department of Internal Medicine, Academic Medical Center, Amsterdam, The Netherlands. 3. Department of Public Health, Academic Medical Center, Amsterdam, The Netherlands. 4. Department of Cardiology, Academic Medical Center, Amsterdam, The Netherlands. 5. Department of Vascular Medicine, Academic Medical Center, Amsterdam, The Netherlands.
Abstract
AIMS: Evidence of ethnic disparities in the conversion of prediabetes to type 2 diabetes is scarce. We studied the association of impaired fasting glucose (IFG) and fasting plasma glucose (FPG) with the 10-year cumulative incidence of type 2 diabetes in three ethnic groups. METHODS: We analyzed data for 90 South-Asian Surinamese, 190 African-Surinamese, and 176 ethnic Dutch that were collected in the periods 2001-2003 and 2011-2012. We excluded those with type 2 diabetes or missing FPG data. We defined baseline IFG as FPG of 5.7-6.9 mmol/L. We defined type 2 diabetes at follow-up as FPG ≥ 7.0 mmol/L, HbA1c ≥ 48 mmol/mol (6.5%), or self-reported type 2 diabetes. RESULTS: 10-Year cumulative incidences of type 2 diabetes were: South-Asian Surinamese, 18.9%; African-Surinamese, 13.7%; ethnic Dutch, 4.5% (p<0.05). The adjusted association of baseline IFG and FPG with the 10-year cumulative incidence of type 2 diabetes was stronger for South-Asian Surinamese than for African-Surinamese and ethnic Dutch. The IFG (compared to normoglycaemia) ORs were 11.1 [3.0-40.8] for South-Asian Surinamese, 5.1 [2.0-13.3] for African-Surinamese, and 2.2 [0.5-10.1] for ethnic Dutch. CONCLUSIONS: The 10-year cumulative incidence of type 2 diabetes was higher and associations with baseline IFG and FPG were stronger among South-Asian Surinamese and African-Surinamese than among ethnic Dutch. Our findings confirm the high risk of type 2 diabetes in South-Asians and suggest more rapid conversion in populations of South-Asian origin and (to a lesser extent) African origin than European origin.
AIMS: Evidence of ethnic disparities in the conversion of prediabetes to type 2 diabetes is scarce. We studied the association of impaired fasting glucose (IFG) and fasting plasma glucose (FPG) with the 10-year cumulative incidence of type 2 diabetes in three ethnic groups. METHODS: We analyzed data for 90 South-Asian Surinamese, 190 African-Surinamese, and 176 ethnic Dutch that were collected in the periods 2001-2003 and 2011-2012. We excluded those with type 2 diabetes or missing FPG data. We defined baseline IFG as FPG of 5.7-6.9 mmol/L. We defined type 2 diabetes at follow-up as FPG ≥ 7.0 mmol/L, HbA1c ≥ 48 mmol/mol (6.5%), or self-reported type 2 diabetes. RESULTS: 10-Year cumulative incidences of type 2 diabetes were: South-Asian Surinamese, 18.9%; African-Surinamese, 13.7%; ethnic Dutch, 4.5% (p<0.05). The adjusted association of baseline IFG and FPG with the 10-year cumulative incidence of type 2 diabetes was stronger for South-Asian Surinamese than for African-Surinamese and ethnic Dutch. The IFG (compared to normoglycaemia) ORs were 11.1 [3.0-40.8] for South-Asian Surinamese, 5.1 [2.0-13.3] for African-Surinamese, and 2.2 [0.5-10.1] for ethnic Dutch. CONCLUSIONS: The 10-year cumulative incidence of type 2 diabetes was higher and associations with baseline IFG and FPG were stronger among South-Asian Surinamese and African-Surinamese than among ethnic Dutch. Our findings confirm the high risk of type 2 diabetes in South-Asians and suggest more rapid conversion in populations of South-Asian origin and (to a lesser extent) African origin than European origin.
Authors: Sophie V Eastwood; Therese Tillin; Naveed Sattar; Nita G Forouhi; Alun D Hughes; Nish Chaturvedi Journal: Diabetes Care Date: 2015-10-20 Impact factor: 19.112
Authors: Meghana D Gadgil; Alka M Kanaya; Caroline Sands; Matthew R Lewis; Namratha R Kandula; David M Herrington Journal: Diabet Med Date: 2020-12-25 Impact factor: 4.359
Authors: Irene G M van Valkengoed; Carmen Argmann; Karen Ghauharali-van der Vlugt; Johannes M F G Aerts; Lizzy M Brewster; R J G Peters; Frédéric M Vaz; Riekelt H Houtkooper Journal: Nutr Diabetes Date: 2017-12-19 Impact factor: 5.097
Authors: Mirthe Muilwijk; Dirk Jan Stenvers; Mary Nicolaou; Andries Kalsbeek; Irene G M van Valkengoed Journal: Obesity (Silver Spring) Date: 2020-05-21 Impact factor: 5.002
Authors: Jason Martin Regnald Gill; Naveed Sattar; Carlos Celis-Morales; Mirthe Muilwijk; Frederick Ho; Heather Waddell; Anne Sillars; Paul Welsh; Stamatina Iliodromiti; Rosemary Brown; Lyn Ferguson; Karien Stronks; Irene van Valkengoed; Jill P Pell; Stuart Robert Gray Journal: BMJ Open Diabetes Res Care Date: 2019-12-17